ArticleBritish journal of clinical pharmacology2018

Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with haematological malignancies.

Pier Giorgio Cojutti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.